Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...
Pennsylvania’s universities - Pitt, UPenn and Penn State in particular - have big reputations, and to back them up, they ...
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Addressing challenges and opportunities in meeting the UN Sustainable Development Goals and what ESG characteristics underpin share prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback